What is XEOMIN?
Marketed by Merz Aesthetics, XEOMIN is an injectable that contains botulinum toxin type a. It is approved for medical use in 14 countries in the European Union, including Germany, the UK, France, Italy and Spain, where it is marketed under the name BOCOUTURE®.
Who’s a Candidate for XEOMIN?
XEOMIN is FDA approved and indicated for temporary improvement in the appearance of glabellar lines – the frown lines that reside between your eyebrows, on the smooth part of the forehead.
Botulinum type a products are typically recommended for cosmetic treatment of:
- Forehead lines
- Frown lines (on the glabella)
- Crow’s feet
If you are bothered by these conditions, ask a physician about treatment with XEOMIN. Notify your physician if you have a known hypersensitivity to botulinum toxin type A or if you have an infection at the proposed injection site(s).
How does XEOMIN work?
Your physician at the Metro Health Cosmetic Treatment Center injects XEOMIN directly into muscles to decrease their activity. The drug blocks the release of a chemical messenger known as acetylcholine, which sends a signal from the nerves thats causes muscles to contract. The muscles can still contract, but they do it less forcefully, which helps to treat wrinkles and muscle spasms.
Does XEOMIN have possible side effects?
Possible side effects after treatment of blepharospasm include but are not limited to drooping eyelid, dry eye, dry mouth, diarrhea, and headache. Possible side effects after treatment of blepharospasm cervical dystonia include difficulty swallowing, neck pain, muscle weakness, injection site pain, and muscle/joint pain. XEOMIN can also cause serious side effects that can be life threatening.
How is XEOMIN Different?
XEOMIN is the only botulinum toxin currently approved in the U.S. that does not require refrigeration prior to reconstitution.
XEOMIN is not identical to other botulinum toxin products – that’s why it has a different name. The XEOMIN dose chosen by your physician may be different from other botulinum toxin medications.